uFluidix highlights the work of Dr. Ben Pope
uFluidix highlighted one of the technologies invented by our CSO that enables adipocyte hypertrophy in vitro. Follow the link below to see the peer-reviewed scientific article. See the post here.
News
4 Comments:
Leave a Reply
MelliCell develops drug therapies that shrink fat cells in order to treat diabetes and other metabolic diseases like obesity
Copyright © 2024 MelliCell. All Rights Reserved.
Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen.